Junxia Xie

Shandong Provincial Key Laboratory Of Pathogenesis And Prevention Of Neurological Disorders
Qingdao, 266021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson's disease.

Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson's disease.

Journal: Science advances

Published: May 01, 2026

Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics.

Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics.

Journal: Neuroscience bulletin

Published: November 21, 2025

Effect of 6-Hydroxydopamine on Iron Metabolism in MO3.13 Oligodendrocytes.

Effect of 6-Hydroxydopamine on Iron Metabolism in MO3.13 Oligodendrocytes.

Journal: Neurochemical research

Published: February 26, 2025

The beneficial pharmacological effects of Uncaria rhynchophylla in neurodegenerative diseases: focus on alkaloids.

The beneficial pharmacological effects of Uncaria rhynchophylla in neurodegenerative diseases: focus on alkaloids.

Journal: Frontiers in pharmacology

Published: May 22, 2024

Yeast Prion Protein Sup35 Initiates α-Synuclein Pathology in Parkinson's Disease.

Yeast Prion Protein Sup35 Initiates α-Synuclein Pathology in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: December 28, 2023

Ferritin Is Secreted from Primary Cultured Astrocyte in Response to Iron Treatment via TRPML1-Mediated Exocytosis.

Ferritin Is Secreted from Primary Cultured Astrocyte in Response to Iron Treatment via TRPML1-Mediated Exocytosis.

Journal: Cells

Published: August 30, 2023

Contrasting Iron Metabolism in Undifferentiated Versus Differentiated MO3.13 Oligodendrocytes via IL-1β-Induced Iron Regulatory Protein 1.

Contrasting Iron Metabolism in Undifferentiated Versus Differentiated MO3.13 Oligodendrocytes via IL-1β-Induced Iron Regulatory Protein 1.

Journal: Neurochemical research

Published: August 12, 2023

Updates on brain regions and neuronal circuits of movement disorders in Parkinson's disease.

Updates on brain regions and neuronal circuits of movement disorders in Parkinson's disease.

Journal: Ageing research reviews

Published: July 28, 2023

Heme oxygenase-1: The roles of both good and evil in neurodegenerative diseases.

Heme oxygenase-1: The roles of both good and evil in neurodegenerative diseases.

Journal: Journal of neurochemistry

Published: July 12, 2023

Commentary: The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.

Commentary: The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.

Journal: Frontiers in aging neuroscience

Published: May 16, 2023

TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner.

TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner.

Journal: Free radical biology & medicine

Published: May 09, 2023

Chemogenetic and optogenetic stimulation of zona incerta GABAergic neurons ameliorates motor impairment in Parkinson's disease.

Chemogenetic and optogenetic stimulation of zona incerta GABAergic neurons ameliorates motor impairment in Parkinson's disease.

Journal: iScience

Published: January 17, 2023

Showing 1-12 of 70

Last Updated: 09/26/2026